指南与共识炎症性肠病

英国胃肠病学会关于COVID-19大流行期间炎症性肠病管理的指南

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
指南 / 共识 · Gut · 2020-04-17

英国胃肠病学会COVID-19 IBD工作组利用现有最佳数据和专家意见,制定风险分层网格,将IBD患者分为最高、中、最低风险类别,分别对应shield、严格和标准社交距离建议。指南还涉及服务提供、药物与手术治疗、内镜、影像和临床试验的考量。

要点

  • BSG制定风险网格将IBD患者分为三类风险等级。
  • 最高风险者建议shield,中风险者严格社交距离,低风险者标准建议。
  • 需关注免疫抑制药物影响及内镜等服务的调整。

核心结论

  • BSG COVID-19 IBD工作组基于最佳可用数据和专家意见生成风险网格,指导IBD患者分层管理。

研究设计与样本

  • BSG COVID-19 IBD工作组制定指南,使用最佳可用数据和专家意见。

主要发现

  • 风险网格将患者分为最高、中、最低风险类别,分别对应shield、严格和标准社交距离建议。

关键数值与推荐

  • 最高风险患者应遵循shield建议,中风险患者遵循严格社交距离,最低风险患者遵循标准建议。

临床怎么用

  • 根据风险分层对IBD患者进行社交距离指导,并考虑服务提供、药物手术、内镜、影像和临床试验的调整。

局限性

  • 新型冠状病毒未知因素多,缺乏不同免疫抑制药物影响的资料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Kennedy NA, Jones GR, Lamb CA, et al. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020. PMID: 32303607. doi:10.1136/gutjnl-2020-321244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。